Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.5000
+0.0160
+(3.31%)
At close: 4:00:00 PM EDT
0.5099
+0.01
+(1.98%)
After hours: 4:42:34 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.11 | -0.12 | -0.28 | -0.4 |
| Low Estimate | -0.11 | -0.12 | -0.28 | -0.4 |
| High Estimate | -0.11 | -0.12 | -0.28 | -0.4 |
| Year Ago EPS | -0.17 | -0.23 | -1.01 | -0.28 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 2M | 1.2M | 13.3M | 7.7M |
| Low Estimate | 2M | 1.2M | 13.3M | 7.7M |
| High Estimate | 2M | 1.2M | 13.3M | 7.7M |
| Year Ago Sales | 447k | 466k | 1.55M | 13.3M |
| Sales Growth (year/est) | 347.43% | 157.51% | 755.86% | -42.11% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.17 | -0.16 | -0.19 | -0.05 |
| EPS Actual | -0.17 | -0.23 | 0.07 | -0.01 |
| Difference | 0 | -0.07 | 0.26 | 0.04 |
| Surprise % | 2.86% | -43.75% | 136.84% | 80.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.11 | -0.12 | -0.28 | -0.4 |
| 7 Days Ago | -0.2 | -0.17 | -0.31 | -0.47 |
| 30 Days Ago | -0.2 | -0.17 | -0.31 | -0.47 |
| 60 Days Ago | -0.2 | -0.17 | -0.31 | -0.49 |
| 90 Days Ago | -0.18 | -0.17 | -0.83 | -0.49 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SLGL | 35.29% | 47.83% | 72.28% | -42.86% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Downgrade | Raymond James: Strong Buy to Outperform | 8/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/22/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/20/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
| Maintains | Raymond James: Strong Buy to Strong Buy | 8/11/2023 |
Related Tickers
XTLB XTL Biopharmaceuticals Ltd.
1.2300
0.00%
CSCI COSCIENS Biopharma Inc.
2.7150
-2.69%
PLRZ Polyrizon Ltd.
0.3590
-8.42%
ENTO Entero Therapeutics, Inc.
0.4370
+6.30%
CUS0.SG Curis Inc.
1.2400
-9.49%
VALN Valneva SE
6.97
-0.43%
NBY NovaBay Pharmaceuticals, Inc.
0.5623
-1.70%
COOL.CN Core One Labs Inc.
0.1450
0.00%
OBIO Orchestra BioMed Holdings, Inc.
3.1100
-11.65%
SLNCF Silence Therapeutics plc
0.8500
+0.59%